Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in calabar, Nigeria

BACKGROUND: The use of anti-malarial drug combinations with artemisinin, or with one of its derivatives, is now widely recommended to overcome drug resistance in falciparum malaria. Fixed-dose combination of artemisinin and naphthoquine is a new generation artemisinin combination therapy (ACT) offer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Meremikwu, Martin M, Odey, Friday, Oringanje, Chioma, Oyo-ita, Angela, Effa, Emmanuel, Esu, Ekpereonne B, Eyam, Eyam, Oduwole, Olabisi, Asiegbu, Vivian, Alaribe, Ambrose, Ezedinachi, Emmanuel N
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2012
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3538558/
https://ncbi.nlm.nih.gov/pubmed/23232095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-11-413
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia